Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00788346 · ClinicalTrials.gov registry record · NA
Reducing the Unnecessary Use of Heavily Marketed Medications: A Randomized Controlled Trial
A NA study, sponsored by VA Boston Healthcare System.
- Completed
- Registry status
- NA
- Development phase
- 257
- Enrollment target
NCT00788346 is a NA study that has completed, run by VA Boston Healthcare System. The registered enrollment target is 257 participants.
The verdict
NCT00788346, a NA study, has completed, sponsored by VA Boston Healthcare System.
- COMPLETED
- Registry status
- NA
- Development phase
- 257 participants
- Enrollment target
Study Summary
Prescribing decisions by clinicians are often thought to be simple: a patient's clinical problem leads a prescriber to choose the optimal treatment. However, many factors other than the patient's condition affect prescribing decisions, including the marketing of pharmaceuticals. Clinicians are subjected to direct "detailing" by representatives of the pharmaceutical industry, advertisements in medical journals and requests for specific treatments from patients, who are increasingly exposed to direct-to-consumer (DTC) advertising. These influences, often based on biased or inaccurate information, contribute to a variety of problems in prescribing, including the unnecessary use of expensive, heavily marketed medications. Overcoming these influences requires innovative approaches. The movement toward widespread adoption of electronic health records (EHRs) and electronic prescribing presents new opportunities to educate both clinicians and patients at the time of medication prescribing. This project, endorsed by the AHRQ-supported Centers for Education and Research on Therapeutics (CERTs; www.certs.hhs.gov) and the U.S. Food and Drug Administration (FDA), aims to test the effectiveness of computerized prescribing alerts and state-of-the-art educational outreach to reduce the unnecessary use of heavily marketed medications. A second goal is to improve clinicians' knowledge of industry marketing practices, so that they can more effectively assess information provided by drug companies. Thus, the study has two specific aims: Specific Aim 1: To assess whether computerized prescribing alerts linked electronically to patient educational material can reduce prescribing of heavily marketed medications. Specific Aim 2: To assess whether group academic detailing increases clinicians' knowledge about industry marketing practices and increases the effect of prescribing alerts.
Interventions
- BEHAVIORAL Computerized alerts
- BEHAVIORAL Alerts Plus Detailing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 257 participants |
| Start Date | 2007-03 |
| Est. Completion | 2008-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00788346
The ClinicalTrials.gov registry entry for NCT00788346 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 257 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Boston Healthcare System, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Computerized alerts is the first listed.
NCT00788346 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00788346 about?
NCT00788346 is a clinical study titled "Reducing the Unnecessary Use of Heavily Marketed Medications: A Randomized Controlled Trial". Prescribing decisions by clinicians are often thought to be simple: a patient's clinical problem leads a prescriber to choose the optimal treatment. However, many factors other than the patient's condition affect prescribing decisions, including the marketing of pharmaceuticals. Clinicians are subje...
What is the current status of trial NCT00788346?
This trial is currently completed. It is a NA study. The enrollment target is 257 participants. The study started on 2007-03. Estimated completion is 2008-03.
What interventions are being tested in trial NCT00788346?
The interventions under investigation include: Computerized alerts (BEHAVIORAL), Alerts Plus Detailing (BEHAVIORAL).
Who is sponsoring clinical trial NCT00788346?
This trial is sponsored by VA Boston Healthcare System, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.